Lyell Immunopharma 株価情報 (NASDAQ: LYEL)

最新ニュース Lyell Immunopharma (NASDAQ:LYEL) 株価情報

LYELL IMMUNOPHARMA INC

Lyell Immunopharma

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Lyell Immunopharma Inc

Raymond James analyst Patrick Tyler Brown maintains FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Outperform and lowers the price target from $275 to $260.

News

Price Target

Analyst Ratings

Raymond James Maintains Outperform on FedEx, Lowers Price Target to $260

Raymond James analyst Brian Gesuale reiterates AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) with a Strong Buy and raises the price target from $200 to $225.

Reiteration

AVAV

Raymond James Reiterates Strong Buy on AeroVironment, Raises Price Target to $225

Raymond James analyst Sam Darkatsh downgrades GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) from Outperform to Market Perform.

Downgrades

Raymond James Downgrades GMS to Market Perform

WIIM

BOOM

FANG

NINE

RCON

Shares of oil-related companies are trading higher. The commodity may be seeing a price increase due to a rebound after falling amid escalating Iran-Israel tensions.

Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) has outperformed the market over the past 5 years by 11.64% on an annualized basis producing an average annual return of 26.14%. Currently, Williams Companies has a market capitalization of $74.26 billion. 
Buying $1000 In WMB: If an investor had bought $1000 of WMB stock 5 years ago, it would be worth $3,306.21 today based on a price of $60.82 for WMB at the time of writing.
<h3>Williams Companies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750870312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Kellanova Now Expects Merger With Mars To Close Towards End Of 2025

<a href="https://apnews.com/article/getty-images-stability-ai-copyright-trial-stable-diffusion-7208c729fb10c1f133cb49da2065d72a">https://apnews.com/article/getty-images-stability-ai-copyright-trial-stable-diffusion-7208c729fb10c1f133cb49da2065d72a</a>

General

GETY

'Getty Drops Copyright Allegations In UK Lawsuit Against Stability AI'- AP News

NVDA

NVIDIA shares are trading higher after Loop Capital maintained a Buy rating and raised its price target from $175 to $250.

Morgan Stanley analyst Erik Woodring maintains TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) with a Overweight and raises the price target from $145 to $155.

Morgan Stanley Maintains Overweight on TD Synnex, Raises Price Target to $155

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 0.2% on Wednesday.
The Dow traded down 0.18% to 43,011.70 while the NASDAQ gained 0.20% to 19,953.27. The S&amp;P 500 also rose, gaining, 0.02% to 6,093.14.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a>
Leading and Lagging Sectors Information technology shares jumped by 0.8% on Wednesday.
In trading on Wednesday, real estate stocks fell by 1.3%.
Top Headline
U.S. crude oil inventories declined by 5.836 million barrels in the week ended June 20, compared to market estimates of a 0.75 million barrel fall.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Plus Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares shot up 59% to $0.2968 after the company announced FDA clearance of its investigational new drug application for REYOBIQ to treat childhood brain cancer.</li>
<li>Shares of QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) got a boost, surging 36% to $5.88 after the company achieved a key 2025 milestone by successfully integrating its advanced Cobra separator process into baseline cell production.</li>
<li>SeaStar Medical Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) shares were also up, gaining 49% to $0.5362 after the company announced it is taking strategic actions to regain Nasdaq compliance.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Lifeward Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFWD#NASDAQ">LFWD</a>) shares dropped 38% to $0.6015 after the company announced the pricing of a $2.6 million public offering of 4 million shares and warrants at a combined price of $0.65 per share and associated ordinary warrant.</li>
<li>Shares of Torrid Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) were down 37% to $3.1900 after the company announced the pricing of a secondary offering of 10 million shares at $3.50 per share.</li>
<li>Allot Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLT#NASDAQ">ALLT</a>) was down, falling 17% to $8.01 after the company announced the pricing of its $40 million public offering of 5 million shares at $8.00 per shares.</li>
</ul>
Commodities In commodity news, oil traded up 2.5% to $65.99 while gold traded up 0.3% at $3,343.80.
Silver traded up 1% to $36.070 on Wednesday, while copper rose 0.7% to $4.9605.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.74%, while Spain's IBEX 35 Index fell 1.59%. London's FTSE 100 fell 0.46%, Germany's DAX 40 fell 0.61% and France's CAC 40 slipped 0.76% during the session.
Asia Pacific Markets
Asian markets closed higher on Wednesday, with Japan's Nikkei gaining 0.39%, Hong Kong's Hang Seng Index gaining 1.23%, China's Shanghai Composite rising 1.04% and India's BSE Sensex rising 0.85%.
Economics
<ul class="wp-block-list">
<li>Sales of new single-family homes in the U.S. dipped by 13.7% from the previous month to an annualized rate of 623,000 units in May.</li>
<li>U.S. building permits declined by 2% to an annualized rate of 1.394 million in May.</li>
<li>U.S. volume of mortgage applications increased by 1.1% from the previous week in the week ending June 20.</li>
<li>U.S. crude oil inventories declined by 5.836 million barrels in the week ended June 20, compared to market estimates of a 0.75 million barrel fall.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46093500/how-to-earn-500-a-month-from-micron-technology-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Micron Technology Stock Ahead Of Q3 Earnings</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

ALLT

CURV

LFWD

PSTV

Crude Oil Rises Sharply; Torrid Holdings Shares Plunge

Ford Motor To Require Most Salaried Staff In Office 4 Days A Week Starting September 1

<a href="https://ec.europa.eu/commission/presscorner/detail/en/ip_25_1604" title="https://ec.europa.eu/commission/presscorner/detail/en/ip_25_1604">https://ec.europa.eu/commission/presscorner/detail/en/ip_25_1604</a>

Reported June 24, 2025: EU Antitrust Regulators To Investigate Mars' $36B Takeover Of Kellanova; The Transaction Could Lead To Higher Prices For Consumers Due To Mars' Increased Negotiating Power Towards Retailers In The European Economic Area; EU Sets Oct 31 2025 Deadline For Decision On Deal

BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) stock is trading higher Wednesday after the company reported better-than-expected first-quarter <a href="https://www.benzinga.com/markets/earnings/25/06/46084802/blackberry-stock-climbs-after-better-than-expected-q1-report-details">financial results</a>.
What To Know: BlackBerry <a href="https://www.benzinga.com//node/46084333">reported first-quarter</a> adjusted earnings per share of 2 cents, beating the consensus estimate for breakeven earnings. In addition, BlackBerry reported sales of $121.7 million, beating the consensus estimate of $112.18 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Broken down by segment, the company reported that QNX revenue came in at $57.5 million, up 8% year-over-year, and Secure Communications revenue came in at $59.5 million.
Blackberry ended the quarter with $381.9 million in cash, cash equivalents and short-term and long-term investments, down $28.4 million sequentially. The company said it repurchased 2.57 million shares throughout the quarter.
Q2 Outlook: BlackBerry expects earnings per share of breakeven to one cent, versus the consensus estimate of one cent. Furthermore, the company sees sales from $115 million to $125 million, versus the consensus estimate of $122.35 million.
FY26 Outlook: Blackberry anticipates adjusted earnings per share of eight cents to 10 cents, versus the consensus estimate of 10 cents. Additionally, the company now expects sales from $508 million to $538 million, versus the consensus estimate of $513.51 million. The company previously expected sales of $504 million to $534 million.
Analysts Changes: Following the earnings report, multiple analysts issued price target adjustments.
<ul class="wp-block-list">
<li>Baird analyst Luke Junk maintained a Neutral rating on BlackBerry and raised the price target from&nbsp;$4&nbsp;to&nbsp;$5.</li>
<li>Canaccord Genuity analyst Kingsley Crane maintained a Hold rating on BlackBerry and raised the price target from $4.25 to $4.60.</li>
<li>RBC Capital analyst Paul Treiber maintained a Sector Perform rating on BlackBerry and raised the price target from&nbsp;$3.75&nbsp;to&nbsp;$4.</li>
</ul>
See Also: <a href="https://www.benzinga.com/etfs/sector-etfs/25/06/46098656/nvidia-amazon-tesla-among-tech-stocks-hedge-funds-are-piling-into-heres-how-etfs-like-ivv-spy-voo-are-riding-the-wave">Nvidia, Amazon, Tesla Among Tech Stocks Hedge Funds Are Piling Into — Here&#8217;s How ETFs Like IVV, SPY, VOO Are Riding The Wave</a>
BB Price Action: At the time of writing, Blackberry stock was up 16.2% at $5.02, according to data from <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Image via Shutterstock.

BlackBerry Stock Is Rising Wednesday: What's Going On?

Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are trading higher Wednesday afternoon. The company on Tuesday <a href="https://www.benzinga.com/news/financing/25/06/46074323/supermicro-raises-2-billion-via-private-convertible-debt-with-35-conversion-premium">announced</a> the pricing of its $2 billion convertible senior notes due 2030. Shares are recovering from a near 10% drop on Monday, when the initial debt proposal triggered investor concerns about potential stock dilution.
What To Know: In the Tuesday announcement, the company detailed its plans to limit that dilution. Super Micro is using a portion of the proceeds for capped call transactions, which effectively limit the number of shares to be issued. 
The notes feature an initial conversion price of roughly $55.20 per share, a 35% premium over the company's June 23, closing price of $40.89. The cap price for the transactions is set at $81.78 per share, a 100% premium.
Super Micro <a href="https://www.benzinga.com/news/financing/25/06/46074323/supermicro-raises-2-billion-via-private-convertible-debt-with-35-conversion-premium">expects</a> net proceeds of $1.96 billion from the offering, with a $300 million over-allotment option. The company plans to use $158.4 million to fund the capped call transactions and another $200 million to repurchase approximately 4.9 million of its shares.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46036770/whats-going-on-with-super-micro-computer-smci-stock-7">What&#8217;s Going On With Super Micro Computer Stock?</a>
Analyst Coverage: Based on recent analyst ratings, Wall Street has shown a mixed but <a href="https://www.benzinga.com/quote/SMCI/analyst-ratings">recently more positive outlook</a> on Super Micro. On May 19, Mizuho maintained its Neutral rating on the stock while increasing its price target from $32 to $40. 
Earlier in the month, on May 13, Raymond James initiated coverage with an Outperform rating and a price target of $41. This followed a series of updates on May 7, where analysts expressed varied opinions. Notably, Rosenblatt maintained a Buy rating while lowering its price target from $55 to $50. 
On the same day, Wedbush and Citigroup both maintained &#8220;Neutral&#8221; ratings with price target adjustments, while Needham reinstated its coverage with a Buy rating and a $29 price target.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SMCI shares are trading higher by 5.7% to $45.28 Wednesday afternoon. SMCI has a 52-week high of $96.33 and a 52-week low of $17.25.
Read Also: <a href="https://www.benzinga.com/pressreleases/25/06/b46066482/supermicro-announces-pricing-of-private-offering-of-2-0-billion-of-convertible-senior-notes-due-20">Supermicro Announces Pricing of Private Offering of $2.0 Billion of Convertible Senior Notes Due 2030</a>
<h2 class="wp-block-heading">How To Buy SMCI Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Super Micro Computer&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

SMCI

Super Micro Computer (SMCI) Stock Is Surging Today: What's Going On?

SHEL

Reuters Cites Shell Spokesperson Saying In Regard To Market Speculation About Shell Considering Buying BP That No Talks Are Taking Place

U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Wednesday.
Shares of AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) rose sharply during Wednesday's session after the company reported <a href="https://www.benzinga.com/markets/earnings/25/06/46083155/aerovironment-stock-sinks-despite-better-than-expected-q4-report-heres-why">better-than-expected quarterly financial results</a>.
AeroVironment reported quarterly earnings of $1.61 per share, which beat the $1.42 analyst consensus estimate, according to data from Benzinga Pro. Quarterly revenue came in at&nbsp; $275.05 million, beating the Street estimate of $242.69 million.
AeroVironment shares jumped 24% to $239.57 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) shares jumped 34.1% to $32.81. Nektar Therapeutics recently announced data from the 16-week induction period of the ongoing Phase 2b REZOLVE-AD study of investigational rezpegaldesleukin.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) gained 31.6% to $5.70 after the company achieved a key 2025 milestone by successfully integrating its advanced Cobra separator process into baseline cell production.</li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) jumped 27.1% to $30.61.</li>
<li>Bumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) jumped 19.9% to $6.24. 19.7% to $6.24 after the company announced it is reducing the size of its team.</li>
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) rose 19.1% to $31.77.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) gained 18.1% to $9.60.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) rose 16.3% to $5.03 after the company reported better-than-expected first-quarter financial results and raised its FY26 sales guidance.</li>
<li>Yatsen Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) gained 15.1% to $11.12.</li>
<li>Chime Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) rose 13% to $32.77.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) gained 9.8% to $7.26 after Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $6 to $11.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) rose 9.5% to $35.25.</li>
<li>Light &amp; Wonder, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNW#NASDAQ">LNW</a>) gained 9.1% to $93.65.</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) rose 8.6% to $13.70.</li>
<li>TTM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) gained 6% to $40.12.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) jumped 5.5% to $45.18.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june">Top 3 Real Estate Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutterstock

Movers

BMBL

CHYM

LIMN

NKTR

NNNN

TIGR

TTMI

AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday

HPE And KDDI Collaborate To Open Osaka Sakai Data Center By Early 2026 To Support Startups, Enterprises With NVIDIA AI Infrastructure For Developing AI Applications And Training LLMs

<a href="https://techcrunch.com/2025/06/25/intel-hits-the-brakes-on-its-automotive-business-and-layoffs-have-started/#:~:text=Intel%20is%20shuttering%20its%20automotive,shared%20with%20employees%20Tuesday%20morning" title="https://techcrunch.com/2025/06/25/intel-hits-the-brakes-on-its-automotive-business-and-layoffs-have-started/#:~:text=Intel%20is%20shuttering%20its%20automotive,shared%20with%20employees%20Tuesday%20morning">https://techcrunch.com/2025/06/25/intel-hits-the-brakes-on-its-automotive-business-and-layoffs-have-started/#:~:text=Intel%20is%20shuttering%20its%20automotive,shared%20with%20employees%20Tuesday%20morning</a>.

INTC

MBLY

'Intel Hits The Brakes On Its Automotive Business, And Layoffs Have Started' - TechCrunch

Science Applications International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) shares rose on Wednesday after the company secured a significant <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g46093311/saic-awarded-928-million-prototype-engineering-and-mission-integration-contract" rel="noreferrer noopener">new defense contract from the U.S. government</a>.
The award, part of the Department of Defense&#8217;s mission to rapidly modernize its military capabilities, is poised to further solidify SAIC&#8217;s role in high-tech national defense efforts.
The company will lead the $928 million Hyper-Innovative Operational Prototype Engineering, or HOPE 2.0 initiative, under the U.S. Air Force Tactical Exploitation of National Capabilities (AF TENCAP) program, slated to begin in July 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/06/46047038/spotifys-daniel-ek-leads-690-million-bet-on-defense-ai-startup-helsing-valued-at-13-8-billion-as-europe-ramps-up-military-spending" rel="noreferrer noopener">Spotify&#8217;s Daniel Ek Leads $690 Million Bet On Defense AI Startup Helsing, Valued At $13.8 Billion As Europe Ramps Up Military Spending</a>
The contract will enhance the Air Force&#8217;s ability to quickly prototype and deploy advanced intelligence and operational systems.
Science Applications will deliver full-spectrum research, development, testing, and engineering support under HOPE 2.0.
The project is designed to fast-track the transition of innovative prototypes into near-operational tools that meet the Defense Department&#8217;s evolving requirements.
The initiative emphasizes agility, integrating commercial technology and data-driven strategies to outpace adversaries.
The scope of work includes enhancing decision-making capabilities through advanced sensor integration, improving command-and-control systems, supporting Special Operations Forces, and developing cutting-edge cyber tools.
By fusing intelligence and operational data, the goal is to equip warfighters with superior situational awareness and technological advantage across land, air, cyber, and space domains.
Science Applications will collaborate with over a dozen traditional and emerging defense firms to support the needs of 65 military and intelligence agencies.
&#8220;We&#8217;re excited to help Air Force TENCAP achieve evolutionary and revolutionary warfighting improvements,&#8221; said Vincent DiFronzo, Executive Vice President at SAIC, who emphasized the urgency of integrated mission systems for modern threats.
The HOPE 2.0 award aligns with national defense priorities, including deterrence in the Pacific and space-based defense initiatives like Golden Dome.
The project also matches the Defense Department&#8217;s Software Acquisition Pathway, aiming to cut lead times and boost innovation.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, SAIC stock has lost over 8% in the past year. Investors can gain exposure to the stock via iShares Cybersecurity and Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHAK#NYSE">IHAK</a>).
Price Action: SAIC shares are trading higher by 2.44% to $107.52 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/25/06/46045060/bitcoin-ethereum-dogecoin-fall-as-us-involvement-in-iran-israel-war-threatens-oil-prices-spike-arthur-hayes-says-weakness-shall-pass-and-btc-will-show-its-safe-haven-status" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Fall As US Involvement In Iran-Israel War Threatens Oil Prices Spike: Arthur Hayes Says &#8216;Weakness Shall Pass&#8217; And BTC Will Show Its Safe Haven Status</a></li>
</ul>
Photo by DCStockPhotography via Shutterstock

Contracts

Tech

IHAK

SAIC

SAIC Lands Nearly $1 Billion Contract To Modernize US Air Force

Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAHC#NASDAQ">PAHC</a>) with a Equal-Weight and raises the price target from $21 to $26.

PAHC

Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $26

Health Care

Press Releases

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments

Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma

Comments

Lyell Immunopharma

ニュース

最新ニュース Lyell Immunopharma (NASDAQ:LYEL) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル